Kevin Kotler, 10% Owner at Aegerion Pharmaceuticals, Inc. (AEGR), bought 40,100 shares at $10.96 ($440K) on 2015-11-11, disclosed to the SEC on 2015-11-13.
Open-market purchase of $440k AEGR by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.96 | 35,000 | $384K | 87.3% |
| 2 | $10.99 | 5,100 | $56K | 12.7% |
| Total | $10.96 avg | 40,100 | $440K | 100% |
| Filing → |
| BDSI | SELL | 2019-04-15 | $10.0M | — | Filing → |
| NVLN | SELL | 2018-12-27 | $483K | — | Filing → |
| REPH | SELL | 2017-12-22 | $750K | — | Filing → |